Search

everythinglearnresearchcommunity

for

Search:↓

Lower vitamin D levels may contribute to female hair loss.

Feather patterns form through genetic and epigenetic controls, with cells self-organizing into periodic patterns.

Yellow dots and short vellus hairs are the most common signs of Alopecia Areata (AA), and trichoscopy can help diagnose AA and track treatment progress.

Hair loss can be managed with treatments like minoxidil, finasteride, and others, but there are still gaps in effectiveness and off-label usage is increasing.

Different ethnic groups have unique hair growth patterns, with African hair growing slower and less dense, Asian hair growing fast but sparse, and Caucasian hair being densest; men are more likely to experience hair loss than women.

Different types of hair loss need specific treatments, and while many classification systems exist, each has its flaws; more research is needed to refine these systems and treatments.

Hormonal therapies like cyproterone acetate and spironolactone may help some women with hair loss, but finasteride 1mg is not useful, and the effectiveness of other treatments is still unclear.

Injectable platelet-rich fibrin improves hair growth and reduces hair loss in women.

About one-third of Saudi women with female pattern hair loss also have thinning hair at the back of their head.

Hormonal therapy like cyproterone acetate and spironolactone may help female hair loss, but more research is needed, especially for pre-menopausal women.

Nutritional supplements may help improve hair growth in female pattern hair loss.

Feather growth and regeneration involve complex patterns, stem cells, and evolutionary insights.

Annurca apple extract may help treat hair loss and protect against oxidative stress.

Understanding tissue self-organization can improve treatments for diseases and advance regenerative medicine.

Trichoscopy effectively shows early positive effects of minoxidil in male pattern hair loss, improving patient satisfaction.

Certain gene changes and hormone levels are linked to female hair loss.

Hormone replacement therapy may improve hair growth in the frontal hairline of postmenopausal women with hair loss.

Many women with hair loss also have zinc deficiency, iron depletion, or thyroid issues.

Female pattern hair loss does not significantly affect sexual dysfunction.

Lymphoma should be considered in unusual scalp hair loss cases, as treatment can work but may lead to severe complications.

Androgenetic alopecia, a common hair loss condition, can be treated with topical minoxidil, oral finasteride, or oral spironolactone, and new treatments like platelet-rich plasma, low-level laser therapy, and janus-kinase inhibitors are being explored.

Extracellular vesicles may effectively treat hair loss with minimal side effects.

Microfluidics can create precise, efficient delivery systems for food and cosmetics, but scaling up is challenging.

Low vitamin D levels are linked to increased risk of male pattern baldness.

An 86-year-old man with prostate cancer was diagnosed with a rare, low-grade breast cancer and underwent surgery but declined additional hormone therapy.

Droplet-based microfluidics improves delivery of bioactive compounds in food using precise encapsulation and release.

Safusidenib erbumine shows promise as a treatment for certain brain tumors, but mild side effects like hair loss need attention.

S100A4 promotes aggressive ovarian cancer and is a potential treatment target.

Non-scarring hair loss is common in lupus patients and can be diagnosed with specific hair and tissue tests.